Peripheral arterial tonometry versus polysomnography in suspected obstructive sleep apnoea

Table 4 Follow-up parameters in patients with or without PAP therapy/prescription stratified by matched concordant and matched discordant measurements

	Matched concordant no PAP therapy n = 122; n (%), Mean ± SEM	Matched concordant with PAP therapy n = 152; n (%), Mean ± SEM	p-value^*	Matched discordant no PAP therapy n = 144; n (%), Mean ± SEM	Matched discordant with PAP therapy n = 11; n (%), Mean ± SEM	p-value^*
Follow-up time (days)	1184 ± 39	1184 ± 31	0.970	1190 ± 38	1167 ± 151	0.09
MACE after diagnosis	6 (5)	7 (5)	0.608	7 (4)	2 (18)	0.14
Death from any cause	4 (3)	2 (1)	0.412	2 (2)	1 (7)	0.20

PAT peripheral arterial tonometry, PSG polysomnography, MACE major adverse cardiovascular events
^*p-values determined using the Chi-square test if variable is categorical and the Mann–Whitney U-test if continuous

ISSN: 2047-783X